Clinical Neuroscience Solutions, Inc

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension	cardiovascular disorder, hypertensive disorder, vascular disorder	Active, not recruiting	Phase 3	2026-09-29	NCT05968430
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Active, not recruiting	Phase 3	2026-09-28	NCT06564818
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Enrolling by invitation	Phase 3	2026-09-25	NCT06605105
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)	anxiety disorder, generalized anxiety disorder, psychiatric disorder	Active, not recruiting	Phase 3	2026-09-04	NCT06809595
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis	Acute Gastroenteritis; Norovirus Acute Gastroenteritis	Active, not recruiting	Phase 3	2026-05-13	NCT06592794

Clinical trials